Cargando…

Nrf2 Activators as Attractive Therapeutics for Diabetic Nephropathy

Detalles Bibliográficos
Autor principal:	de Haan, Judy B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2011
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198074/ https://www.ncbi.nlm.nih.gov/pubmed/22025774 http://dx.doi.org/10.2337/db11-1072

Ejemplares similares

Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
por: Zheng, Hongting, et al.
Publicado: (2011)

Nrf2 Is an Attractive Therapeutic Target for Retinal Diseases
por: Nakagami, Yasuhiro
Publicado: (2016)

Bilirubin: A Potential Biomarker and Therapeutic Target for Diabetic Nephropathy
por: Hull, Travis D., et al.
Publicado: (2014)

Prevention of Diabetic Complications by Activation of Nrf2: Diabetic Cardiomyopathy and Nephropathy
por: Li, Bing, et al.
Publicado: (2012)

Is There a Sweet Spot for Nrf2 Activation in the Treatment of Diabetic Kidney Disease?
por: Hall, Evan T., et al.
Publicado: (2014)

On the scent of sexual attraction
por: Brennan, Peter A
Publicado: (2010)

Does Losartan Prevent Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes?
por: Nicholas, Susanne B., et al.
Publicado: (2013)

The Challenging Search for Diabetic Nephropathy Genes
por: Bowden, Donald W., et al.
Publicado: (2012)

Prevention of Diabetic Nephropathy by Sulforaphane: Possible Role of Nrf2 Upregulation and Activation
por: Cui, Wenpeng, et al.
Publicado: (2012)

The ethical dimension in published animal research in critical care: the dark side of our moon
por: Huet, Olivier, et al.
Publicado: (2014)

Urinary adiponectin and progression of diabetic nephropathy in type 1 diabetes
por: Ha, Kyoung Hwa, et al.
Publicado: (2015)

Losartan and diabetic nephropathy: commentaries on the RENAAL study
por: Fisman, Enrique Z, et al.
Publicado: (2002)

Diabetic Nephropathy: Emerging Biomarkers for Risk Assessment
por: Badal, Shawn S., et al.
Publicado: (2015)

The Protective Role of Nrf2 in Streptozotocin-Induced Diabetic Nephropathy
por: Jiang, Tao, et al.
Publicado: (2010)

Ameliorating diabetes-associated atherosclerosis and diabetic nephropathy through modulation of soluble guanylate cyclase
por: Sharma, Arpeeta, et al.
Publicado: (2023)

Values and Limitations of Targeting lncRNAs in Diabetic Nephropathy
por: Long, Jianyin, et al.
Publicado: (2018)

A commentary on the VITAL study: Does vitamin D (receptor activation) protect against nephropathy in type 2 diabetes?
por: Okada, Shinichi, et al.
Publicado: (2011)

The nuclear factor (erythroid-derived 2)-like 2 (Nrf2) activator dh404 protects against diabetes-induced endothelial dysfunction
por: Sharma, Arpeeta, et al.
Publicado: (2017)

Vitamin D in diabetic nephropathy
por: Prabhu, RA, et al.
Publicado: (2018)

Annexin 1 Mimetic Ac2-26 Holds Promise for the Treatment of Diabetic Nephropathy
por: Pan, Yu, et al.
Publicado: (2021)

Protective Effect of Nrf2 and Catalase in Maternal Diabetes-Induced Perinatal Hypertension and Kidney Disease
por: Vaziri, Nosratola D.
Publicado: (2012)

Artificial Lighting as a Vector Attractant and Cause of Disease Diffusion
por: Barghini, Alessandro, et al.
Publicado: (2010)

Phytochemical activators of Nrf2: a review of therapeutic strategies in diabetes: Phytochemical activators of Nrf2
por: Qin, Si, et al.
Publicado: (2022)

Mitochondrial reactive oxygen species in the pathogenesis of early diabetic nephropathy
por: Nishikawa, Takeshi, et al.
Publicado: (2015)

Epidermal growth factor receptor signaling and the progression of diabetic nephropathy
por: Koya, Daisuke
Publicado: (2015)

CREDENCE: A silver lining in the dark cloud of diabetic nephropathy
por: Hanai, Ko, et al.
Publicado: (2019)

Targeting Nrf2 for the treatment of Duchenne Muscular Dystrophy
por: Kourakis, Stephanie, et al.
Publicado: (2020)

Linking Klotho, Nrf2, MAP kinases and aging
por: Balasubramanian, Priya, et al.
Publicado: (2010)

Fatal attraction: why breast cancer cells home to bone
por: Hofbauer, Lorenz C, et al.
Publicado: (2008)

Commentary: Juxtaposition of the atrial appendages: Fatal attraction or benign coupling?
por: Abdullah, Ibrahim
Publicado: (2021)

Cholesterol Accumulation in Podocytes: A Potential Novel Targetable Pathway in Diabetic Nephropathy
por: Tufro, Alda
Publicado: (2013)

Rumex nervosus could alleviate streptozotocin-induced diabetic nephropathy in rats by activating Nrf2 signaling
por: AlMousa, Lujain A, et al.
Publicado: (2022)

Nrf2: new insight in cell apoptosis
por: Bonay, M, et al.
Publicado: (2015)

NFkB and Nrf2 in esophageal epithelial barrier function
por: Chen, Hao, et al.
Publicado: (2013)

Network meta-analysis-highly attractive but more methodological research is needed
por: Li, Tianjing, et al.
Publicado: (2011)

Biomarkers That Predict Diabetic Nephropathy: The Long Road From Finding Targets to Clinical Use
por: Klein, Jon
Publicado: (2012)

The sponging effect of a lncRNA on a miRNA contributes to diabetic nephropathy
por: Pasupulati, Anil K., et al.
Publicado: (2022)

Fatal Attraction Evaded: How Pathogenic Bacteria Resist Cationic Polypeptides
por: Ganz, Tomas
Publicado: (2001)

WJ-39, an Aldose Reductase Inhibitor, Ameliorates Renal Lesions in Diabetic Nephropathy by Activating Nrf2 Signaling
por: Zhou, Xiaoyu, et al.
Publicado: (2020)

The GSK-3β/Fyn/Nrf2 pathway in fibroblasts and wounds of type 2 diabetes: On the road to an evidence-based therapy of non-healing wounds
por: Bitar, Milad S.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_8dl9h088jrs87ghl37gu4tbf06